These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6886585)

  • 1. Serum lipids and glucose concentrations in subjects using antihypertensive drugs: Finnmark 1977.
    Arnesen E; Thelle DS; Førde OH; Mjøs OD
    J Epidemiol Community Health; 1983 Jun; 37(2):141-4. PubMed ID: 6886585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prazosin on serum lipids.
    Kokubu T; Itoh I; Kurita H; Ochi T; Murata K; Yuba I
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S228-32. PubMed ID: 6177962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of hypertensive status and its drug treatment with lipid and haemostatic factors in middle-aged men: the PRIME study.
    Marques-Vidal P; Montaye M; Haas B; Bingham A; Evans A; Juhan-Vague I; Ferrières J; Luc G; Amouyel P; Arveiler D; McMaster D; Ruidavets JB; Bard JM; Scarabin PY; Ducimetière P
    J Hum Hypertens; 2000 Aug; 14(8):511-8. PubMed ID: 10962519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biochemical effects of antihypertensive agents and the impact on atherosclerosis.
    Lowenstein J; Neusy AJ
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S262-4. PubMed ID: 6177970
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of antihypertensive drugs on serum lipids and lipoproteins in patients with mild to moderate hypertension.
    Goto Y; Tamachi H
    Jpn J Med; 1989; 28(2):267-8. PubMed ID: 2659858
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive therapy and the risk of coronary heart disease.
    Ames RP; Hill P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S206-12. PubMed ID: 6177958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive and metabolic effects of tiapamil.
    Ding YA; Shieh SM
    J Clin Pharmacol; 1990 Mar; 30(3):262-6. PubMed ID: 2312781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Age and dynamics of the chief blood lipid indices among the adult population of Leningrad].
    Klimov AN; Shestov DB; Triufanov VF; Alksnis EG; Teriukova NP
    Kardiologiia; 1984 Apr; 24(4):56-62. PubMed ID: 6233447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study.
    MacMahon SW; Macdonald GJ; Blacket RB
    Arteriosclerosis; 1985; 5(4):391-6. PubMed ID: 4015511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of vascular hydrostatic pressure on the plasma concentrations of HDL-cholesterol, LDL-cholesterol and triglycerides in healthy subjects].
    Rodríguez Portillo M; Fabiani Romero F; Trujillo Rodríguez F
    Rev Clin Esp; 1981 Aug 15-31; 162(3-4):111-4. PubMed ID: 7313202
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adrenergic mechanisms and their significance for plasma lipid concentrations].
    Day JL
    Wien Med Wochenschr; 1982; 132 Spec No 2():19-22. PubMed ID: 6132497
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced high density lipoprotein in stroke: relationship with elevated triglyceride and hypertension.
    Taggart H; Stout RW
    Eur J Clin Invest; 1979 Jun; 9(3):219-21. PubMed ID: 225176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term antihypertensive and hypolipidemic treatment on high density lipoprotein cholesterol and apolipoproteins A-I and A-II.
    Miettinen TA; Huttunen JK; Ehnholm C; Kumlin T; Mattila S; Naukkarinen V
    Atherosclerosis; 1980 Jun; 36(2):249-59. PubMed ID: 6773532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of thyroid function on serum lipid profile.
    Raziel A; Rosenzweig B; Botvinic V; Beigel I; Landau B; Blum I
    Atherosclerosis; 1982 Feb; 41(2-3):321-6. PubMed ID: 7066080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.
    Rössner S
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S201-5. PubMed ID: 6177957
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.